Skip to main content
Signal8

Gilliland Robertson H.

SEC insider (Form 3/4/5 filer). CIK 0001718351. Director at ADIAL PHARMACEUTICALS, INC. (ADIL). 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2026. Located in GLEN ALLEN, VA.

Companies Gilliland Robertson H. has filed insider reports for

  • ADIAL PHARMACEUTICALS, INC. (ADIL): Director
Gilliland Robertson H. profile photo

Gilliland Robertson H.

CIK: 0001718351

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ADIAL PHARMACEUTICALS, INC. logo
ADIL

ADIAL PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • ADIAL PHARMACEUTICALS, INC. logo
    ADIL

    ADIAL PHARMACEUTICALS, INC.

    Apr 7, 2026
    Award
    Direct
    9.2K shares-
  • ADIAL PHARMACEUTICALS, INC. logo
    ADIL

    ADIAL PHARMACEUTICALS, INC.

    May 29, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    28K shares-

1-2 of 2